Citigroup Cuts Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $26.00
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) had its price target trimmed by Citigroup from $27.00 to $26.00 in a ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript November 26, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
Algert Global LLC Sells 3,480 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Algert Global LLC reduced its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 8.6% in ...
bovnews18h
What Factors Have Led to Arrowhead Pharmaceuticals Inc (ARWR) Stock Trading -34.35% Below Its 52-Week High?
Goldman has recently initiated Arrowhead Pharmaceuticals Inc (ARWR) stock to Neutral rating, as announced on June 5, 2024, according to Finviz. Earlier, on December 4, 2023, BofA Securities had ...
Arrowhead price target lowered to $24 from $27 at Bernstein
Bernstein lowered the firm’s price target on Arrowhead (ARWR) to $24 from $27 and keeps a Market Perform rating on the shares. The company’s ...
Zacks.com on MSN17h
Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?
Shares of Sarepta Therapeutics SRPT have soared 43% year to date, significantly outperforming the industry’s 6.9% decline.
Sky23h
Ukraine war latest: MI6 uncovers 'staggeringly reckless' Russian sabotage in Europe; Ukraine hits oil depot
The head of MI6 says British security will be "jeopardised" if Putin is allowed to succeed in Ukraine, as he warned the spy agency has already uncovered a Russian sabotage campaign in Europe.